147 related articles for article (PubMed ID: 29987902)
1. Identification of ENTPD8 and cytidine in pancreatic cancer by metabolomic and transcriptomic conjoint analysis.
An Y; Cai H; Yang Y; Zhang Y; Liu S; Wu X; Duan Y; Sun D; Chen X
Cancer Sci; 2018 Sep; 109(9):2811-2821. PubMed ID: 29987902
[TBL] [Abstract][Full Text] [Related]
2. Integration of metabolomic and transcriptomic data reveals metabolic pathway alteration in breast cancer and impact of related signature on survival.
Luo X; Yu H; Song Y; Sun T
J Cell Physiol; 2019 Aug; 234(8):13021-13031. PubMed ID: 30556899
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-Induced Metabolomic Alterations in Pancreatic Cancer Cells.
Gunda V; Kumar S; Dasgupta A; Singh PK
Methods Mol Biol; 2018; 1742():95-105. PubMed ID: 29330793
[TBL] [Abstract][Full Text] [Related]
4. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
[TBL] [Abstract][Full Text] [Related]
5. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N
J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582
[TBL] [Abstract][Full Text] [Related]
6. Integration of metabolomic and transcriptomic profiles to identify biomarkers in serum of lung cancer.
Sun Q; Zhao W; Wang L; Guo F; Song D; Zhang Q; Zhang D; Fan Y; Wang J
J Cell Biochem; 2019 Jul; 120(7):11981-11989. PubMed ID: 30805978
[TBL] [Abstract][Full Text] [Related]
7. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
8. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination.
Itoi T; Sugimoto M; Umeda J; Sofuni A; Tsuchiya T; Tsuji S; Tanaka R; Tonozuka R; Honjo M; Moriyasu F; Kasuya K; Nagakawa Y; Abe Y; Takano K; Kawachi S; Shimazu M; Soga T; Tomita M; Sunamura M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375170
[TBL] [Abstract][Full Text] [Related]
9. Plasma, urine and ligament tissue metabolite profiling reveals potential biomarkers of ankylosing spondylitis using NMR-based metabolic profiles.
Wang W; Yang GJ; Zhang J; Chen C; Jia ZY; Li J; Xu WD
Arthritis Res Ther; 2016 Oct; 18(1):244. PubMed ID: 27770826
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential biomarkers and metabolic pathways based on integration of metabolomic and transcriptomic data in the development of breast cancer.
Yang Y; Zhu Y; Li X; Zhang X; Yu B
Arch Gynecol Obstet; 2021 Jun; 303(6):1599-1606. PubMed ID: 33791842
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.
Di Gangi IM; Mazza T; Fontana A; Copetti M; Fusilli C; Ippolito A; Mattivi F; Latiano A; Andriulli A; Vrhovsek U; Pazienza V
Oncotarget; 2016 Feb; 7(5):5815-29. PubMed ID: 26735340
[TBL] [Abstract][Full Text] [Related]
12. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine.
Liang JH; Lin Y; Ouyang T; Tang W; Huang Y; Ye W; Zhao JY; Wang ZN; Ma CC
World J Gastroenterol; 2019 Jul; 25(25):3218-3230. PubMed ID: 31333313
[TBL] [Abstract][Full Text] [Related]
13. Accelerated, untargeted metabolomics analysis of cutaneous T-cell lymphoma reveals metabolic shifts in plasma and tumor adjacent skins of xenograft mice.
Le Y; Shen X; Kang H; Wang Q; Li K; Zheng J; Yu Y
J Mass Spectrom; 2018 Feb; 53(2):172-182. PubMed ID: 29160924
[TBL] [Abstract][Full Text] [Related]
14. A joint analysis of transcriptomic and metabolomic data uncovers enhanced enzyme-metabolite coupling in breast cancer.
Auslander N; Yizhak K; Weinstock A; Budhu A; Tang W; Wang XW; Ambs S; Ruppin E
Sci Rep; 2016 Jul; 6():29662. PubMed ID: 27406679
[TBL] [Abstract][Full Text] [Related]
15. UPLC‑MS/MS‑based metabolomic characterization and comparison of pancreatic adenocarcinoma tissues using formalin‑fixed, paraffin‑embedded and optimal cutting temperature‑embedded materials.
Feng D; Yuan J; Liu Q; Liu L; Zhang X; Wu Y; Qian Y; Chen L; Shi Y; Gu M
Int J Oncol; 2019 Dec; 55(6):1249-1260. PubMed ID: 31638165
[TBL] [Abstract][Full Text] [Related]
16. Integrative Analysis of Metabolomic and Transcriptomic Data Reveals Metabolic Alterations in Glioma Patients.
Shi Y; Ding D; Liu L; Li Z; Zuo L; Zhou L; Du Q; Jing Z; Zhang X; Sun Z
J Proteome Res; 2021 May; 20(5):2206-2215. PubMed ID: 33764076
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.
Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L
Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790
[TBL] [Abstract][Full Text] [Related]
18. A metabolomic approach to identifying platinum resistance in ovarian cancer.
Poisson LM; Munkarah A; Madi H; Datta I; Hensley-Alford S; Tebbe C; Buekers T; Giri S; Rattan R
J Ovarian Res; 2015 Mar; 8():13. PubMed ID: 25880539
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of transcriptomic and metabolomic data demonstrates the significant role of pyruvate carboxylase in the progression of ovarian cancer.
Shang H; Zheng J; Tong J
Aging (Albany NY); 2020 Nov; 12(21):21874-21889. PubMed ID: 33177242
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
